Mycobacterial lipid-derived immunomodulatory drug- liposome conjugate eradicates endosome-localized mycobacteria
- 14 July 2023
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 360, 578-590
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Critical Roles for Lipomannan and Lipoarabinomannan in Cell Wall Integrity of Mycobacteria and Pathogenesis of TuberculosismBio, 2013
- Evaluation of the humoral immune response and cross reactivity against Mycobacterium tuberculosis of mice immunized with liposomes containing glycolipids of Mycobacterium smegmatisBMC Immunology, 2013
- Evaluation of specific humoral immune response and cross reactivity against Mycobacterium tuberculosis antigens induced in mice immunized with liposomes composed of total lipids extracted from Mycobacterium smegmatisBMC Immunology, 2013
- Cell death and infection: A double-edged sword for host and pathogen survivalJournal of Cell Biology, 2011
- Prophylactic Effect of a Therapeutic Vaccine against TB Based on Fragments of Mycobacterium tuberculosisPLOS ONE, 2011
- Lipidomic analyses of Mycobacterium tuberculosis based on accurate mass measurements and the novel “Mtb LipidDB”Journal of Lipid Research, 2011
- Mycobacterium tuberculosis WhiB3 Maintains Redox Homeostasis by Regulating Virulence Lipid Anabolism to Modulate Macrophage ResponsePLOS Pathogens, 2009
- Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages:in vitroandin vivoevaluationJournal of Liposome Research, 2009
- Lysosomal killing ofMycobacteriummediated by ubiquitin-derived peptides is enhanced by autophagyProceedings of the National Academy of Sciences, 2007
- Trehalose 6,6′-Dimycolate (Cord Factor) ofMycobacterium tuberculosisInduces Foreign-Body- and Hypersensitivity-Type Granulomas in MiceInfection and Immunity, 2001